---
$id: https://graph.org.ai/products/commodity/51151516
$type: Product
source: UNSPSC
code: "51151516"
title: "Tacrine"
class: "51151500"
classTitle: "Cholinergic drugs and cholinesterase inhibitors"
family: "51150000"
familyTitle: "Autonomic nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Tacrine

**UNSPSC Code**: 51151516
**Class**: [Cholinergic drugs and cholinesterase inhibitors](Cholinergic drugs and cholinesterase inhibitors.mdx)
**Family**: [Autonomic nervous system drugs](../Autonomic nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an acetylcholinesterase inhibitor with the molecular formula C13H14N2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4VX7YNB537, chemically known as 1,2,3,4-tetrahydro-acridin-9-ylamine but generally known as tacrine, which bears US NIH Compound Identifier 1935. European Medicines Agency schedules Tacrine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10796MIG. The term TACRINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 16, No. 3 1962, List 4). World Health Organization schedules tacrine in its Anatomical Therapeutic Chemical (ATC) Classification. TACRINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule tacrine under HS 29339990 and SITC 51577. As of Q4 2014, TACRINE remains the US FDA Preferred Term for this commodity. Tacrine bears US NLM identifiers UMLS ID C0039245 and NCI Concept Code C61961. SMILES: N1C2C(CCCC2)C(N)C2C1CCCC2.

